1-7 of 7
Diana Quinlan, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus.

Alejandra Ugarte-Torres, MD, Yiping Liu, PhD, Tyler Williamson, Mette Hoegh-Petersen, MD, Diana Quinlan, RN, Lina Roa, Faisal Khan, PhD, James A. Russell, MD, Jan Storek, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2248.
https://doi.org/10.1182/blood.V114.22.2248.2248
Published: 2009
Journal Articles

Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.

Pedro R. Camacho, MD-R, James Russell, MD, Karen Shepard, RN, Diana Quinlan, RN, Jan Mclaughlin, RN
Journal: Blood
Blood (2007) 110 (11): 4987.
https://doi.org/10.1182/blood.V110.11.4987.4987
Published: 2007
Journal Articles

Total Body Irradiation (TBI) Added to Fludarabine/Busulfan/Antithymocyte Gobulin (FLUBUP/ATG) Conditioning Increases Overall Survival and Relapse-Free Survival in Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Stem Cell Transplants.

Mary Lynn Savoie, MD, Alexander Balogh, MD, Ahsan Chaudhry, MD, Douglas A. Stewart, MD, Nizar J. Bahlis, MD, Jan Storek, MD,PhD, Christopher Brown, MD,PhD, Diana Quinlan, RN, Leanne Kmet, PhD, Loree M. Larratt, MD, A. Robert Turner, MD, James A. Russell, FRCPE
Journal: Blood
Blood (2006) 108 (11): 3010.
https://doi.org/10.1182/blood.V108.11.3010.3010
Published: 2006
Journal Articles

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

Farrukh Naveed, BSc, Shahbal Kangarloo, BSc, MSc, Ahsan Chaudhry, BSc, MD, Michelle Geddes, BSc, MD, Diana Quinlan, RN, BN, CCRP, James Russell, MA, MB, BChir, FRCPE
Journal: Blood
Blood (2006) 108 (11): 2941.
https://doi.org/10.1182/blood.V108.11.2941.2941
Published: 2006
Journal Articles

Once Daily IV Busulfan Given with Fludarabine in Allogeneic Stem Cell Transplantation Conditioning: High vs Low Busulfan AUC Does Not Alter Toxicities or Transplant Outcome.

Michelle Geddes, MD, Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Ahsan M. Chaudhry, MD, Oluyemi Jeje, MD, Mary L. Savoie, MD, Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Christopher Brown, MD, Jan Storek, MD, PhD, Diana Quinlan, RN, Borje Andersson, MD, James A. Russell, MBBChir
Journal: Blood
Blood (2005) 106 (11): 1763.
https://doi.org/10.1182/blood.V106.11.1763.1763
Published: 2005
Journal Articles

Adult Recipients of Matched Related Donor Blood Cell Transplants (BCT) Given Pretransplant Low-Dose Antithymocyte Globulin (ATG) Have Less Chronic Graft-Versus-Host Disease (cGVHD) and Transplant-Related Mortality (TRM): A Matched Pair Analysis.

James A. Russell, FRCPE, A. Robert Turner, MD3, Loree Larratt, MD, Ahsan M. Chaudhry, MD, Oluyeme Jeje, MD, Don Morris, MD, Christopher B. Brown, MD, Lynne Savoie, MD, Nizhar Bahlis, MD, Diana Quinlan, RN, Douglas Stewart, MD
Journal: Blood
Blood (2004) 104 (11): 2250.
https://doi.org/10.1182/blood.V104.11.2250.2250
Published: 2004
Journal Articles

Adult Matched Sibling Blood Cell Transplants (BCT) after Myeloablative Conditioning Incorporating Daily Intravenous (IV) Busulfan (BU) and Low-Dose Antithymocyte Globulin (ATG): Outcomes with Particular Respect to Transplant-Related Mortality (TRM) in 140 Patients.

James A. Russell, FRCP, Ahsan M. Chaudhy, MD, Oluyeme Jeje, MD, Diana Quinlan, RN, Douglas Stewart, MD, Donald Morris, MD, Nizhar J. Bahlis, MD, Lynne Savoie, MD, Christopher B. Brown, MD, Loree Larratt, MD, Michelle Geddes, MD, A. Robert Turner, MD
Journal: Blood
Blood (2004) 104 (11): 2313.
https://doi.org/10.1182/blood.V104.11.2313.2313
Published: 2004